Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C

DD SHOCK, K HE, JD WENCEL-DRAKE… - Biochemical …, 1997 - portlandpress.com
DD SHOCK, K HE, JD WENCEL-DRAKE, LV PARISE
Biochemical Journal, 1997portlandpress.com
Several reports have indicated that the small G-protein Ras is not present immunologically
in platelets. However, here we report the identification of Ras in platelets by
immunoprecipitation with the Ras-specific monoclonal antibodies Y13-259 or Y13-238,
followed by Western blotting. The presence of Ras was not due to contamination of samples
with erythrocytes or leucocytes. Immunofluorescence studies indicated that Ras was present
in a peripheral rim pattern in fixed, permeabilized platelets, suggesting an intracellular …
Several reports have indicated that the small G-protein Ras is not present immunologically in platelets. However, here we report the identification of Ras in platelets by immunoprecipitation with the Ras-specific monoclonal antibodies Y13-259 or Y13-238, followed by Western blotting. The presence of Ras was not due to contamination of samples with erythrocytes or leucocytes. Immunofluorescence studies indicated that Ras was present in a peripheral rim pattern in fixed, permeabilized platelets, suggesting an intracellular, plasma membrane location. Activation of platelets with the thrombin receptor peptide42Ő50, the prostaglandin H2/thromboxane A2 mimetic U46619 or phorbol 12-myristate 13-acetate induced a rapid increase in GTP-bound, activated Ras. In each case, this increase was inhibited by the protein kinase C (PKC) inhibitor bisindolylmaleimide GF 109203X, suggesting that Ras is activated downstream of PKC in platelets. Thus the activation of Ras in platelets by agonists will now allow consideration of multiple potential Ras-dependent signal transduction pathways in platelet activation processes.
portlandpress.com